Releaf in the Press: Highlights from the Medical Cannabis Sector 2024
2 min read
Lucy MacKinnon
Contents
Releaf has been at the forefront of the UK medical cannabis sector throughout 2024, garnering widespread media attention for its innovative patient-first approach and groundbreaking initiatives. From leading the conversation around accessibility to driving awareness of medical cannabis treatment options, Releaf has consistently made headlines, shaping the narrative of this rapidly evolving industry. With notable features in national publications and influential platforms, the spotlight on Releaf reflects its commitment to transforming lives and redefining the future of medical cannabis care in the UK.
The Times: June 2024
"Legal cannabis by post: inside the farm behind a British first"
Yahoo! News: November 2024
"Mum praises ‘miracle’ cannabis vape for ‘saving my son’ after mainstream treatments failed"
The Business Desk: October 2024
"Historic medical cannabis deal set to create jobs for Nottingham firm"
Manchester Evening News: November 2024
"Man fit the criteria for a 'cannabis card' after a quick Google"
MSN News: November 2024
"I'm a social worker and I use cannabis daily for health reasons' says 47-year-old Milton Keynes woman"
The Mirror: October 2024
"My son was wasting away, cannabis came to his rescue when doctors couldn’t"
The Daily Start: December 2024
"Releaf medical cannabis helped me reduce my pain and anxiety"
BBC Radio Cambridgeshire: December 2024
Share article
Did you like this article?
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Elevate your wellness with medical cannabis
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Authors
With five years of journalism and healthcare content creation under her belt, Lucy strives to improve medical cannabis awareness and access in the UK by producing high quality, credible content.
Editorial Policy
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
Blog Categories
Further reading
UK medical cannabis for cancer-related pain, nausea, and vomiting in 2026
Cancer and its treatment can be associated with a wide range of symptoms and side effects. As we once again look to raise awareness for those living with cancer this World Cancer Day, we’re assessing the evidence and recommendations for the use of medical cannabis for cancer-related pain, chemotherapy-induced nausea and vomiting, and more.
The Releaf guide to upper back pain causes and treatments options (2026)
Upper back pain can feel tight, sharp, or persistent, often affecting the area between your shoulder blades. This guide explains common causes, what different pain patterns may mean, and the treatment options that can help, including when to seek medical advice and where medical cannabis may fit into a wider pain management plan in 2026.
Decoding Cannabis: missing data in research and what it means for you
Missing data is one of the most common reasons medical cannabis studies can look inconsistent. This Decoding Cannabis guide explains what missing data means, why it happens in real-world research, and how it can affect results without anyone doing anything misleading. You’ll also learn a simple checklist to help you spot higher-quality studies, so you can make more sense of cannabis headlines and claims.